TCL Archive Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”. February 15, 2002
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials November 11, 1983
TCL Archive Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss June 5, 1981
TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. August 13, 2004